BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33976663)

  • 1. Multimodal Imaging Findings and Treatment with Dexamethasone Implant in Three Cases of Idiopathic Macular Telangiectasia Type 1.
    Cirafici P; Musolino M; Saccheggiani M; Traverso CE; Nicolò M
    Case Rep Ophthalmol; 2021; 12(1):92-97. PubMed ID: 33976663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year follow-up of ischemic index changes after intravitreal dexamethasone implant for diabetic macular edema: an ultra-widefield fluorescein angiography study.
    Borrelli E; Parravano M; Querques L; Sacconi R; Giorno P; De Geronimo D; Bandello F; Querques G
    Acta Diabetol; 2020 May; 57(5):543-548. PubMed ID: 31749052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor.
    Couturier A; Rey PA; Erginay A; Lavia C; Bonnin S; Dupas B; Gaudric A; Tadayoni R
    Ophthalmology; 2019 Dec; 126(12):1685-1694. PubMed ID: 31383483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
    Ayachit AG; Reddy LU; Joshi S; Ayachit GS
    Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-Term Assessment of Intravitreal Dexamethasone Implant Using Enhanced-Depth Image Optical Coherence Tomography and Optical Coherence Tomography Angiography in Patients with Retinal Vascular Diseases.
    Minnella AM; Federici M; Pagliei V; Lanza A; Gambini G; Caputo CG; Falsini B; Caporossi A
    Adv Ther; 2019 Feb; 36(2):416-425. PubMed ID: 30565180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
    Eter N; Mohr A; Wachtlin J; Feltgen N; Shirlaw A; Leaback R;
    Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):77-87. PubMed ID: 27460280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.
    Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography angiography in retinal vein occlusion treated with dexamethasone implant: a new test for follow-up evaluation.
    Glacet-Bernard A; Sellam A; Coscas F; Coscas G; Souied EH
    Eur J Ophthalmol; 2016 Aug; 26(5):460-8. PubMed ID: 27405288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macular Telangiectasia Type 2: A Classification System Using MultiModal Imaging MacTel Project Report Number 10.
    Chew EY; Peto T; Clemons TE; Sallo FB; Pauleikhoff D; Leung I; Jaffe GJ; Heeren TFC; Egan CA; Charbel Issa P; Balaskas K; Holz FG; Gaudric A; Bird AC; Friedlander M
    Ophthalmol Sci; 2023 Jun; 3(2):100261. PubMed ID: 36846105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen Retinopathy and Macular Telangiectasia Type 2: Similarities and Differences on Multimodal Retinal Imaging.
    Hess K; Park YJ; Kim HA; Holz FG; Charbel Issa P; Yoon YH; Tzaridis S
    Ophthalmol Retina; 2023 Feb; 7(2):101-110. PubMed ID: 35948211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epiretinal neovascular membrane in Macular Telangiectasia type 2: Multimodal imaging diagnosis.
    Rodríguez-Fernández CA; Morwani R; Arias L
    Eur J Ophthalmol; 2024 Mar; 34(2):NP13-NP16. PubMed ID: 37743592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical bilateral presentation in idiopathic macular telangiectasia type 1.
    Tapia Quijada HE; Mantolan Sarmiento C; Serrano García M; Betancor Caro N
    Arch Soc Esp Oftalmol (Engl Ed); 2021 Nov; 96(11):602-606. PubMed ID: 34756283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
    Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
    Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grading of macular perfusion in retinal vein occlusion using en-face swept-source optical coherence tomography angiography: a retrospective observational case series.
    Moussa M; Leila M; Bessa AS; Lolah M; Abou Shousha M; El Hennawi HM; Hafez TA
    BMC Ophthalmol; 2019 Jun; 19(1):127. PubMed ID: 31182069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of best corrected visual acuity and central macular thickness after intravitreal dexamethasone implant injections in patients with Irvine-Gass syndrome: A retrospective study of six cases.
    Keilani C; Halalchi A; Wakpi Djeugue D; Regis A; Abada S
    Therapie; 2016 Oct; 71(5):457-465. PubMed ID: 27203164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal dexamethasone implant versus anti-VEGF injection for treatment-naïve patients with retinal vein occlusion and macular edema: a 12-month follow-up study.
    Chiquet C; Dupuy C; Bron AM; Aptel F; Straub M; Isaico R; Romanet JP; Creuzot-Garcher C
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2095-102. PubMed ID: 25673251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.